3β-Hydroxysteroid dehydrogenase

Source: Wikipedia, the free encyclopedia.
(Redirected from
3-beta-HSD
)
3β-hydroxysteroid dehydrogenase/Δ-5-4 isomerase
Identifiers
ExPASy
NiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
Search
PMCarticles
PubMedarticles
NCBIproteins
3β-Hydroxysteroid dehydrogenase
Identifiers
SymbolHSD3B
PfamPF01073
InterProIPR002225
Membranome245
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary
Chr. 1 p13-p11
Search for
StructuresSwiss-model
DomainsInterPro
Chr. 1 p13.1
Search for
StructuresSwiss-model
DomainsInterPro

3β-Hydroxysteroid dehydrogenase/Δ5-4 isomerase (3β-HSD) (

testis and placenta. In humans, there are two 3β-HSD isozymes encoded by the HSD3B1 and HSD3B2 genes
.

3β-HSD is also known as delta Δ5-4-isomerase, which catalyzes the oxidative conversion of Δ5-3β-

The 3β-HSD complex is responsible for the conversion of:

Reaction

3β-HSD belongs to the family of oxidoreductases, to be specific, those acting on the CH-OH group with NAD+ or NADP+ as acceptor. This enzyme participates in C21-steroid hormone metabolism and androgen and estrogen metabolism.

3β-HSD catalysis|catalyzes the chemical reaction:

a 3β-hydroxy-Δ5-steroid + NAD+ ⇌ a 3-oxo-Δ5-steroid + NADH + H+

Thus, the two substrates of this enzyme are 3β-hydroxy-Δ5-steroid and NAD+, whereas its three products are 3-oxo-Δ5-steroid, NADH, and H+.

Isozymes

Humans express two 3β-HSD isozymes, HSD3B1 (type I) and HSD3B2 (type II).[3] The type I isoenzyme is expressed in placenta and peripheral tissues, whereas the type II 3β-HSD isoenzyme is expressed in the adrenal gland, ovary, and testis.

Nomenclature

The systematic name of this enzyme class is 3β-hydroxy-Δ5-steroid:NAD+ 3-oxidoreductase. Other names in common use include:

  • progesterone reductase
  • Δ5-3β-hydroxysteroid dehydrogenase
  • 3β-hydroxy-5-ene steroid dehydrogenase
  • 3β-hydroxy steroid dehydrogenase/isomerase
  • 3β-hydroxy-Δ5-C27-steroid dehydrogenase/isomerase
  • 3β-hydroxy-Δ5-C27-steroid oxidoreductase
  • 3β-hydroxy-5-ene-steroid oxidoreductase
  • steroid-Δ5-3β-ol dehydrogenase
  • 3β-HSDH
  • 5-ene-3β-hydroxysteroid dehydrogenase
  • 3β-hydroxy-5-ene-steroid dehydrogenase

Inhibitors

3β-HSD is potently inhibited by azastene, cyanoketone, epostane, and trilostane.[4] Medroxyprogesterone acetate and medrogestone are weak inhibitors of 3β-HSD which may substantially inhibit it at high dosages.

Biosynthetic pathway

Clinical significance

A deficiency in the type II form through mutations in HSD3B2 is responsible for a

rare form of congenital adrenal hyperplasia.[5]
No human condition has yet been linked to a deficiency in the type I enzyme. Its importance in placental progesterone production expression suggests that such a mutation would be embryonically lethal.

The fetal adrenal cortex lacks expression of the enzyme early on, thus

), then glucocorticoids (e.g. cortisol) can be administered.

See also

References

Further reading